China Resources Sanjiu Medical & Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
China Resources Sanjiu Medical & Pharmaceutical has a total shareholder equity of CN¥25.4B and total debt of CN¥2.9B, which brings its debt-to-equity ratio to 11.4%. Its total assets and total liabilities are CN¥40.7B and CN¥15.3B respectively. China Resources Sanjiu Medical & Pharmaceutical's EBIT is CN¥4.3B making its interest coverage ratio -107. It has cash and short-term investments of CN¥8.8B.
Key information
11.4%
Debt to equity ratio
CN¥2.89b
Debt
| Interest coverage ratio | -107x |
| Cash | CN¥8.77b |
| Equity | CN¥25.37b |
| Total liabilities | CN¥15.32b |
| Total assets | CN¥40.70b |
Recent financial health updates
Recent updates
Analysts Are Updating Their China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SZSE:000999) Estimates After Its Second-Quarter Results
Aug 26
Does China Resources Sanjiu Medical & Pharmaceutical (SZSE:000999) Have A Healthy Balance Sheet?
Aug 09Investors Aren't Buying China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s (SZSE:000999) Earnings
Jul 12China Resources Sanjiu Medical & Pharmaceutical (SZSE:000999) Is Increasing Its Dividend To CN¥1.50
Jun 09China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Apr 23An Intrinsic Calculation For China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SZSE:000999) Suggests It's 50% Undervalued
Apr 16Investors Aren't Buying China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s (SZSE:000999) Earnings
Mar 20Do China Resources Sanjiu Medical & Pharmaceutical's (SZSE:000999) Earnings Warrant Your Attention?
Feb 28Financial Position Analysis
Short Term Liabilities: 000999's short term assets (CN¥23.2B) exceed its short term liabilities (CN¥12.6B).
Long Term Liabilities: 000999's short term assets (CN¥23.2B) exceed its long term liabilities (CN¥2.7B).
Debt to Equity History and Analysis
Debt Level: 000999 has more cash than its total debt.
Reducing Debt: 000999's debt to equity ratio has increased from 0.2% to 11.4% over the past 5 years.
Debt Coverage: 000999's debt is well covered by operating cash flow (165.2%).
Interest Coverage: 000999 earns more interest than it pays, so coverage of interest payments is not a concern.